Literature DB >> 9894603

Fusion proteins could generate false positives in peptide phage display.

K K Murthy1, I Ekiel, S H Shen, D Banville.   

Abstract

Fusion proteins are frequently used in the functional characterization of newly discovered proteins and to identify interacting partners. In our study of hPTP1E, a cytosolic protein tyrosine phosphatase, we used glutathione S-transferase (GST)-fusion protein of the second PDZ domain to identify interacting peptide motifs by peptide phage display. A consensus motif G X X V W L G was identified and found to be specific for binding to GST-PDZ2 as determined by ELISA, peptide displacement and by protein overlay. However, using nuclear magnetic resonance (NMR), no interaction of the peptide was observed with PDZ2 alone. In co-precipitation experiments using the consensus peptide cross-linked to Affi-Gel, only GST-PDZ2 (but not PDZ2 or GST alone) could be precipitated. These data suggest that there is a potential for identification of artifacts when using fusion proteins in peptide phage display, and one should exercise caution in interpreting these results. It is critical that the interaction be verified using a second, independent system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9894603     DOI: 10.2144/99261rr03

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  2 in total

1.  Variable surface protein Vmm of Mycoplasma mycoides subsp. mycoides small colony type.

Authors:  Anja Persson; Karin Jacobsson; Lars Frykberg; Karl-Erik Johansson; François Poumarat
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

2.  Functional epitope core motif of the Anaplasma marginale major surface protein 1a and its incorporation onto bioelectrodes for antibody detection.

Authors:  Paula S Santos; Rafael Nascimento; Luciano P Rodrigues; Fabiana A A Santos; Paula C B Faria; João R S Martins; Ana G Brito-Madurro; João M Madurro; Luiz R Goulart
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.